Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma 4Breast Neoplasms 4Sarcoma 3Rhabdomyosarcoma 2Ovarian Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Lung Neoplasms 2Inflammatory Breast Neoplasms 2Fallopian Tube Neoplasms 2Carcinoma 2Teratoma 1Sarcoma, Synovial 1Recurrent Uterine Corpus Sarcoma 1Recurrent Uterine Corpus Carcinoma 1Pancreatic Neoplasms 1Neutropenia 1Neurofibrosarcoma 1Malignant mesenchymal tumor 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Follicular 1Liposarcoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Leiomyosarcoma 1Kidney Neoplasms 1Hodgkin Disease 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Fibrosarcoma 1Esophageal Squamous Cell Carcinoma 1

Interventions

Etoposide 8Cisplatin 6Bleomycin 6Filgrastim 4Peripheral Blood Stem Cell Transplantation 3Ifosfamide 3Carboplatin 3etoposide phosphate 2Thiotepa 2Specimen Handling 2Radiotherapy 2Mesna 2Magnetic Resonance Spectroscopy 2Granulocyte Colony-Stimulating Factor 2sodium thiosulfate 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1liposomal amphotericin B 1Taxes 1Surgical Procedures, Operative 1Standard of Care 1Second-Look Surgery 1Restraint, Physical 1Respiratory Physiological Phenomena 1Reoperation 1Radiation 1Psychiatric Rehabilitation 1Practice Guidelines as Topic 1Polymerase Chain Reaction 1Platinum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Teratoma × pegfilgrastim × Clear all
NCT04684368 2026-05-05

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

Children's Oncology Group

Phase 2 Recruiting
160 enrolled

Choriocarcinoma, Teratoma, Carcinoma, Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡